Effects of rosiglitazone on the IMTc and serum MMP-9 levels in newly diagnosed Type 2 diabetic patients

Journal of Central South University (Medical Sciences)

Volumn 31, Issue 3, 2006, Pages 367-372

  Huang, Zhuo ^a   Lei, Min Xiang ^a   Liu, Lan ^a   Tang, Qi Bin ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Carotid intimamedia thickness; Diabetic; Rosiglitazone; Serum matrix metalloproteinases 9

Indexed keywords

GELATINASE B; METFORMIN; ROSIGLITAZONE;

ARTICLE; CONTROLLED STUDY; ECHOGRAPHY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INTIMA; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS;

ADULT; CAROTID ARTERIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; THIAZOLIDINEDIONES; TUNICA INTIMA; TUNICA MEDIA;

EID: 33745899046     PISSN: 16727347     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Antoniades C, Tousoulis D, Tountas C, et al. Vascular endothelium and inflammatory process, in patients with combined Type 2 diabetes mellitus and coronary atherosclerosis: the effects of vitamin C[J]. Diabetic Medicine, 2004, 21 (6): 552-558.
2. Grouse JR. Predictive value of carotid 2 dimensional ultrasound [J]. Am J Cardiol, 2001, 88(2A): 27E-30E.
3. Torzewski M, Suriyaphol P, Paprotka K, et al. Enzymatic modification of low-density lipoprotein in the arterial wall: a new role for plasmin and matrix metalloproteinases in atherogenesis[J]. Arterioscler Thromb Vasc Biol, 2004, 24 (11): 2130-2136.
4. Chambless LE, Folsom AR, Davis V, et al. Risk factors for progression of common carotid atherosclerosis: the atherosclerosis risk in communities study, 1987-1998[J]. Am J Epidemiol, 2002, 155(1): 38-47.
5. Jarvisalo M, Raitakari M, Toikka J, et al. Endothelial dysfunction and increased arterial intima-media thickness in children with Type I diabetes [J]. Circulation, 2004, 109 (14): 1750-1755.
6. Temelkova K, Theodora S, Koehler C, et al. Increased intimal-media thickness in newly detected Type 2 diabetes: risk factors [J]. Diabetes Care, 1999, 22 (2): 333-338.
7. Guvener N, Tutuncu NB, Oto A, et al. Major determinants of the carotid intima-media thickness in Type 2 diabetic patients: age and body mass index [J]. Endocr J, 2000, 47(4): 525-533.
8. Watarai T, Yamasaki Y, Ikeda M, et al. Insulia resistance contribute to carotid arterial wall thickness in patients with non-insulin-dependent-diabetes mellitus [J]. Endocr J, 1999, 46 (5): 629-638.
9. Nikolaus M, Johannes F, Laila S, et al. Antidiabetic ppar-activator rosiglitazone reduces mmp-9 serum levels in Type 2 diabetic patients with coronary artery disease [J]. Arterioscle Throm Vasc Biol, 2003, 23(2): 283-288.
10. Alison K, Elizabeth J, Fisher M, et al. High glucose alters matrix metalloproteinase expression in two key vascular cell: potential impact on atherosclerosis in diabetes [J]. Atherosclerosis, 2003, 168(3): 263-269.
11. Kalela A, Koivu TA, Sisto T, et al. Serum matrix metalloproteinase-9 concentration in angiographically assessed coronary artery disease [J]. Scand J Clin Lab Invest, 2002, 62(5): 337-342.
12. Ha KT, Lee TK, Kwak KH, et al. Inhibitory effect of Cho-Deung-San on human aortic smooth muscle cell migration induced by TNF-alpha through inhibition of matrix metalloproteinase-2 and -9 activity [J]. Vascul Pharmacol, 2004, 41 (3): 83-90.
13. Collins AR , Meehan WP, Kintscher U, et al. Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient mice [J]. Arterioscler Thromb Vasc Biol, 2001, 21 (3): 365-371.
14. Derosa G , Mugellini A , Ragonesi P, et al. Comparison between glimepiride plus pioglitazone vs glimepiride plus rosiglitazone on glucose metabolism and on lipid , lipoprotein and apolipoprotein fractions in Type 2 diabetic patients [J]. Diabetes, 2003, 52(suppl 1): A458-A459.
15. Jun M, Satsuki T, Mika Y, et al. Potent inhibitory effect of troglitazone on carotid arterial wall thickness in Type 2 diabetes [J]. J Clin Endocrinol Metab, 1998, 83(5): 1818-1820.
16. Li DQ, Lokeshwar BL, Solomon A, et al. Regulation of mmp-9 production by human corneal epithelial cells [J]. Exp Eye Res, 2001, 73(4): 449-459.
17. 2 as a trigger and NF-kappaB as a signal transduce [J]. Thromb Haemost, 2003, 90(3): 528-537.